Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin-Reference-Cited by-同舟云学术

Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin

Published:2010-04 Issue:8 Volume:79 Page:1108-1117
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Beretta Giovanni Luca,Benedetti Valentina,Cossa Giacomo,Assaraf Yehuda G.A.,Bram Eran,Gatti Laura,Corna Elisabetta,Carenini Nives,Colangelo Donato,Howell Stephen B.,Zunino Franco,Perego Paola

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference42 articles.

1. The current treatment of recurrent ovarian cancer;Herzog;Curr Oncol Rep,2006

2. Oxaliplatin clinical activity: a review;Misset;Crit Rev Oncol Hematol,2000

3. Oxaliplatin: a review of preclinical and clinical studies;Raymond;Ann Oncol,1998

4. Oxaliplatin for the treatment of cisplatin-resistant cancer: a systematic review;Stordal;Cancer Treat Rev,2007

5. Clinical application of oxaliplatin in epithelial ovarian cancer;Fu;Int J Gynecol Cancer,2006

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transporter-mediated drug-drug interactions: regulatory guidelines, in vitro and in vivo methodologies and translation, special populations, and the blood-brain barrier;Drug Metabolism Reviews;2024-07-05

2. Meet the Editorial Board Member;Current Medicinal Chemistry;2024-04

3. Drug resistance in ovarian cancer: from mechanism to clinical trial;Molecular Cancer;2024-03-28

4. Peculiarities of interaction of malignant cells and tumors with chemotherapeutic nanocomposite remedies;Surface;2023-12-30

5. Oxaliplatin and its derivatives – An overview;Coordination Chemistry Reviews;2023-12